DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Consensus Recommendation of “Hold” from Analysts

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) have been assigned a consensus rating of “Hold” from the thirteen ratings firms that are presently covering the company, Marketbeat reports. Eleven investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is $20.36.

A number of brokerages have issued reports on XRAY. Morgan Stanley cut DENTSPLY SIRONA from an “overweight” rating to an “equal weight” rating and set a $14.00 target price for the company. in a research report on Tuesday, April 15th. Barrington Research upped their target price on shares of DENTSPLY SIRONA from $20.00 to $21.00 and gave the stock an “outperform” rating in a report on Monday, May 12th. Piper Sandler reduced their target price on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 30th. UBS Group reduced their price target on DENTSPLY SIRONA from $27.00 to $25.00 and set a “buy” rating on the stock in a research report on Friday, May 9th. Finally, Robert W. Baird lowered their price objective on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating for the company in a research report on Friday, February 28th.

DENTSPLY SIRONA Stock Down 2.4%

Shares of DENTSPLY SIRONA stock opened at $15.63 on Monday. The business has a 50-day moving average price of $14.85 and a 200 day moving average price of $16.86. DENTSPLY SIRONA has a fifty-two week low of $12.16 and a fifty-two week high of $27.95. The firm has a market cap of $3.11 billion, a P/E ratio of -7.55, a P/E/G ratio of 1.80 and a beta of 0.95. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.29 by $0.14. The firm had revenue of $879.00 million for the quarter, compared to analyst estimates of $854.75 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. DENTSPLY SIRONA’s revenue was down 7.8% compared to the same quarter last year. During the same period in the previous year, the company earned $0.42 earnings per share. On average, sell-side analysts forecast that DENTSPLY SIRONA will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 11th. Shareholders of record on Friday, June 27th will be issued a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, June 27th. This represents a $0.64 dividend on an annualized basis and a yield of 4.09%. DENTSPLY SIRONA’s dividend payout ratio is currently -14.10%.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. Treasurer of the State of North Carolina raised its position in DENTSPLY SIRONA by 0.6% during the fourth quarter. Treasurer of the State of North Carolina now owns 88,854 shares of the medical instruments supplier’s stock valued at $1,686,000 after purchasing an additional 560 shares during the period. Quarry LP boosted its position in DENTSPLY SIRONA by 25.7% during the 4th quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier’s stock valued at $72,000 after acquiring an additional 780 shares in the last quarter. Federated Hermes Inc. grew its position in shares of DENTSPLY SIRONA by 0.5% in the 4th quarter. Federated Hermes Inc. now owns 169,304 shares of the medical instruments supplier’s stock worth $3,213,000 after buying an additional 915 shares during the last quarter. Gabelli Funds LLC grew its stake in DENTSPLY SIRONA by 1.0% during the 1st quarter. Gabelli Funds LLC now owns 98,000 shares of the medical instruments supplier’s stock worth $1,464,000 after buying an additional 1,000 shares during the last quarter. Finally, Covestor Ltd increased its stake in DENTSPLY SIRONA by 14.9% during the 4th quarter. Covestor Ltd now owns 8,322 shares of the medical instruments supplier’s stock valued at $158,000 after purchasing an additional 1,081 shares in the last quarter. 95.70% of the stock is owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.